ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Nebraska » Endocrinology, Diabetes Metabolism

Top Endocrinology, Diabetes Metabolism Prescribers in Nebraska

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JALAL NAFACH M.D.

Endocrinology, Diabetes Metabolism

8,569

$1.21M

688
418 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 51%

$141
Average prescription price

Avg: $142

TIMOTHY WAHL M.D.

Endocrinology, Diabetes Metabolism

4,379

$588K

342
291 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

53%
prescriptions for brand name drugs

Avg: 51%

$134
Average prescription price

Avg: $142

CLAIRE BAKER M.D.

Endocrinology, Diabetes Metabolism

3,806

$517K

315
215 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

54%
prescriptions for brand name drugs

Avg: 51%

$136
Average prescription price

Avg: $142

ALAIN TAYLON MD

Endocrinology, Diabetes Metabolism

3,531

$539K

295
197 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 51%

$153
Average prescription price

Avg: $142

VICTOR ADALBERT DE VILLA M.D.

Endocrinology, Diabetes Metabolism

3,409

$497K

280
182 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 51%

$146
Average prescription price

Avg: $142

MARC RENDELL M.D.

Endocrinology, Diabetes Metabolism

3,034

$321K

178
119 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 51%

$106
Average prescription price

Avg: $142

MARIUM ILAHI MD

Endocrinology, Diabetes Metabolism

2,984

$525K

244
166 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

53%
prescriptions for brand name drugs

Avg: 51%

$176
Average prescription price

Avg: $142

AMY NEUMEISTER MD

Endocrinology, Diabetes Metabolism

2,018

$335K

226
118 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

54%
prescriptions for brand name drugs

Avg: 51%

$166
Average prescription price

Avg: $142

SARAH KONIGSBERG M.D.

Endocrinology, Diabetes Metabolism

1,912

$279K

186
119 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

55%
prescriptions for brand name drugs

Avg: 51%

$146
Average prescription price

Avg: $142

LYNN MACK MD

Endocrinology, Diabetes Metabolism

1,821

$279K

186
102 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 51%

$153
Average prescription price

Avg: $142

SHANNON WAKELEY M.D.

Endocrinology, Diabetes Metabolism

1,405

$227K

154
93 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

60%
prescriptions for brand name drugs

Avg: 51%

$162
Average prescription price

Avg: $142

ANDJELA DRINCIC M.D.

Endocrinology, Diabetes Metabolism

1,099

$165K

139
80 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 51%

$151
Average prescription price

Avg: $142

WHITNEY GOLDNER MD

Endocrinology, Diabetes Metabolism

1,008

$117K

122
81 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 51%

$116
Average prescription price

Avg: $142

VIJAY SHIVASWAMY M.D.

Endocrinology, Diabetes Metabolism

959

$155K

111
46 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

59%
prescriptions for brand name drugs

Avg: 51%

$161
Average prescription price

Avg: $142

KARA MEINKE BAEHR M.D.

Endocrinology, Diabetes Metabolism

859

$95.1K

93
57 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 51%

$111
Average prescription price

Avg: $142

ROBERT ANDERSON M.D.

Endocrinology, Diabetes Metabolism

726

$51.9K

72
51 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 51%

$72
Average prescription price

Avg: $142

BRIAN BOERNER M.D.

Endocrinology, Diabetes Metabolism

605

$83.8K

84
23 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

60%
prescriptions for brand name drugs

Avg: 51%

$139
Average prescription price

Avg: $142

JENNIFER LARSEN MD

Endocrinology, Diabetes Metabolism

442

$60.6K

44
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

54%
prescriptions for brand name drugs

Avg: 51%

$137
Average prescription price

Avg: $142

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank